FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...
Cancer-associated fibroblasts (CAFs) get a bad rap. The protective, gel-like complex surrounding tumors have been thought to be a no-go for drugs and are known to enforce treatment resistance. But ...
Electrical & Biomedical Engineering Professor Bahram Parvin has received a $2.2 million, five-year award from the National Cancer Institute to develop a new cancer therapy. The next generation of ...
TAMPA, Fla. — Cells in the surrounding tumor microenvironment have a significant impact on cancer growth, survival and responses to therapy. Cancer associated fibroblasts in the tumor environment have ...
HOUSTON ― Cancer cells produce small amounts of their own form of collagen, creating a unique extracellular matrix that affects the tumor microbiome and protects against immune responses, according to ...
Cancer cells produce small amounts of their own form of collagen, creating a unique extracellular matrix that affects the tumor microbiome and protects against immune responses, according to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback